Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics

被引:45
作者
Dekker, FJ
Koch, MA
Waldmann, H
机构
[1] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany
[2] Univ Dortmund, Fachbereich 3, D-44227 Dortmund, Germany
关键词
D O I
10.1016/j.cbpa.2005.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Finding small molecules that modulate protein function is of primary importance in drug development and in the emerging field of chemical genomics. To facilitate the identification of such molecules, we developed a novel strategy making use of structural conservatism found in protein domain architecture and natural product inspired compound library design. Domains and proteins identified as being structurally similar in their ligand-sensing cores are grouped in a protein structure similarity cluster (PSSC). Natural products can be considered as evolutionary pre-validated ligands for multiple proteins and therefore natural products that are known to interact with one of the PSSC member proteins are selected as guiding structures for compound library synthesis. Application of this novel strategy for compound library design provided enhanced hit rates in small compound libraries for structurally similar proteins.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 53 条
[1]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[2]  
Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83
[3]  
BIALY L, 2005, IN PRESS ANGEW CHEM
[4]   Libraries from natural product-like scaffolds [J].
Boldi, AM .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (03) :281-286
[5]  
Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879
[6]   Solid-phase synthesis of dysidiolide-derived protein phosphatase inhibitors [J].
Brohm, D ;
Philippe, N ;
Metzger, S ;
Bhargava, A ;
Müller, O ;
Lieb, F ;
Waldmann, H .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (44) :13171-13178
[7]  
Brohm D, 2002, ANGEW CHEM INT EDIT, V41, P307, DOI 10.1002/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO
[8]  
2-1
[9]   A planning strategy for diversity-oriented synthesis [J].
Burke, MD ;
Schreiber, SL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (01) :46-58
[10]   Leukotriene A4 hydrolase as a target for cancer prevention and therapy [J].
Chen, X ;
Wang, S ;
Wu, N ;
Yang, CS .
CURRENT CANCER DRUG TARGETS, 2004, 4 (03) :267-283